Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined PD-103 prostate implantation and external beam irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 2, 1999, Pages 385-389

  Stock, Richard G ^a   Lo, Yeh Chi ^a   Gaildon, Mohamoud ^a   Stone, Nelson N ^b  

^a Dept Radiat Oncol Mt Sinai S ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Dose volume histogram; Prostate; Seminal vesicles

Indexed keywords

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; HISTOGRAM; IMPLANTATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RISK ASSESSMENT; SEMINAL VESICLE;

BRACHYTHERAPY; HUMANS; MALE; PALLADIUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; SEMINAL VESICLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032867793     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00209-6     Document Type: Article

References (24)

1. Linzer D.G., Stock R.G., Stone N.N., et al. Seminal vesicle biopsy Accuracy and implications for staging of prostate cancer . Urology. 48:1996;757-761.
2. Mukamel E., deKernion J.B., Hannah J., et al. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer. 59:1987;1535-1538.
3. Vallencien G., Bochereau G., Wetzel O., et al. Influence of preoperative positive seminal vesicle biopsy on the staging of prostate cancer. J Urol. 152:1994;1152-1156.
4. Catalona W.J., Smith D.S. 5 year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 152:1994;1837-1842.
5. D'Amico A.V., Whittington R., Malkowicz S.B., et al. A multivariate analysis of clinical and pathological factors that predict for prostate-specific antigen failure after radical prostatectomy for prostate cancer. J Urol. 154:1995;131-138.
6. Zeitman A.L., Edelstein R.A., Coen J.J. Radical prostatectomy for adenocarcinoma of the prostate The influence of preoperative and pathologic findings on biochemical disease-free outcome . Urology. 43:1994;828-833.
7. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 150:1993;110-114.
8. Roach M. Equations for predicting the pathologic stage of men with localized prostate cancer using the preoperative prostate specific antigen. J Urol. 150:1993;1923-1924.
9. Allepuz Lossa C.A., Sanz Velez J.I., Gilsanz M.J., et al. Seminal vesicle biopsy in prostate cancer staging. J Urol. 154:1995;1407-1411.
10. Stock R.G., Stone N.N., Ianuzzi C., et al. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection Implications for patient selection in the radiotherapeutic management of prostate cancer . Int J Radiat Oncol Biol Phys. 33:1995;815-821.
11. Stone N.N., Stock R.G., Unger P. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in the men with localized carcinoma of the prostate. J Urol. 154:1995;1393-1396.
12. Terris M.K., McNeal J.E., Freiha F.S., et al. Efficacy of transrectal ultrasound-guided biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol. 149:1993;1035-1039.
13. Critz F.A., Levinson A.K., Williams W.H., et al. The PSA nadir that indicates potential cure after radiotherapy for prostate cancer. Urology. 49:1997;322-326.
14. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys. 35:1996;875-879.
15. Ragde H., Abdel-Aziz A.E., Snow P.B., et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 83:1998;989-1001.
16. Zeitlin S.I., Sherman J., Raboy A., et al. High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol. 160:1998;91-96.
17. Stock R.G., Stone N.N., Wesson M.F., et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 32:1995;219-225.
18. Stone N.N., Ramin S.A., Wesson M.F., et al. Laparoscopic pelvic lymph node dissection combined with real-time interactive seed implantation of the prostate. J Urol. 153:1995;1555-1560.
19. Stone N.N., Stock R.G., DeWyngaert J.K., et al. Prostate brachytherapy Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three dimensional dosimetry . Radiat Oncol Invest. 3:1995;185-195.
20. Stock R.G., Stone N.N., Tabert A., et al. A dose response study for I-125 prostate implants. Int J Radiat Oncol Biol. 41:1998;101-108.
21. Korman H.J., Watson R.B., Civantos F., et al. Radical prostatectomy Is complete resection of the seminal vesicles really necessary? J Urol. 156:1996;1081-1083.
22. Stone NN, Stock RG. Prostate brachytherapy: Treatment strategies. J Urol In press.
23. Pisansky T.M., Blute M.L., Suman V.J., et al. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys. 36:1996;585-591.
24. Soloway M.S., Sharifi R., Wajsman Z., et al. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. J Urol. 154:1995;424-428.